The Effect of a Suturing Technique on the Gingival Tissues Around Dental Implants (NCT06496776) | Clinical Trial Compass
CompletedNot Applicable
The Effect of a Suturing Technique on the Gingival Tissues Around Dental Implants
Syria14 participantsStarted 2022-09-15
Plain-language summary
There is general agreement that a thick zone of the keratinized tissues around implants promotes accurate prosthetic procedures, permits oral hygiene maintenance, resists recession, and enables esthetic blending with surrounding tissues. A new procedure called Choukroun's technique has been suggested, and it consists of a combination of horizontal apical mattress suture with regular suture to increase the keratinized tissue in the mandibular arch during the first stage after implantation. The proposed procedure has not been evaluated yet in a cohort of patients. Therefore, this study aimed to evaluate the impact of Choukroun's technique on the width and thickness of the keratinized gingiva after oral surgery.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with mandibular missing teeth
* Good oral health
* Good general health
* Male or female
* Age between 18 and 70 years old,
* Thickness of the keratinized gingiva is at least 1 mm,
* The width of the attached gingiva is at least 1 mm.
Exclusion Criteria:
* Patients who are smokers
* Pregnant or lactating women
* Patients with systemic diseases
* Patients who have been taking medication in the last six months that could influence wound healing after surgery and
* Patients with oral inflammation such as periodontal disease.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in the width of the keratinized gingiva
Timeframe: This variable will be measured at one day before surgery (T0), at one month (T1) and two months (T2) after the implant surgical insertion.
2
Change in the thickness of the keratinized gingiva
Timeframe: This variable will be measured at one day before surgery (T0), at one month (T1) and two months (T2) after the implant surgical insertion.